Navigation Links
Neuro Kinetics to Showcase I-Portal® Research at Brain Injury Awareness Day on Capitol Hill

PITTSBURGH, March 15, 2011 /PRNewswire/ -- Neuro Kinetics, Inc. (NKI) (, manufacturers of noninvasive medical diagnostic equipment used worldwide for neurophysiologic/neurotologic testing, said today that it will showcase its eye-tracking I-Portal® technology and the company's collaborative push with the military to develop earlier diagnosis of combat injuries, at the upcoming 2011 Brain Injury Awareness Day on Capitol Hill in Washington, D.C.

The March 16th event is being organized by the Congressional Brain Injury Task Force, a nonpartisan effort of more than 110 Congressional members to raise awareness of brain injuries afflicting millions of Americans -- including soldiers, athletes and accident victims.

"Clearly, there is great urgency to find more accurate ways to diagnose brain injuries and we support efforts to generate interest among our lawmakers," said J. Howison Schroeder, NKI president and CEO. "The data suggests our I-Portal technology is opening a new door to accurate and timely diagnosis of brain injuries. Research with the military and others shows great promise and we are eager to detail the work to members of Congress and their staffs."

NKI currently is involved in collaborative research projects at a number of U.S. military medical facilities to develop and verify a new battery of eye-tracking neurotologic/neurophysiologic tests for earlier and more accurate diagnosis of Traumatic Brain Injury (TBI) and mild TBI.

An estimated 20 percent of soldiers returning from Afghanistan and Iraq suffer from TBI or mTBI resulting from bomb blasts.

NKI's research includes collaboration with specialists at the U.S. Army Aeromedical Research Laboratory (USAARL) at Fort Rucker, Alabama, and other military facilities, including Tripler Army Medical Center (Hawaii), The Traumatic Brain Injury Warrior Resilience and Recovery Center at Fort Campbell (Kentucky) and Walter Reed Army Medical Center (D.C.).

NKI also is involved in a research effort with a large hospital in Western Pennsylvania to gather data from high school and college athletes, part of an effort to improve diagnosis and treatment of sports concussions.

"The eye is the portal to the brain," Schroeder said. "We believe that we are on the verge of a new era in diagnostic testing for a wider range of medical challenges, including new and better ways to diagnose brain injuries."


Neuro Kinetics, Inc. (NKI) is the world leader in eye tracking technology and non-invasive neurophysiologic/neurotologic diagnostic testing.

Central to its product mix and technological advances is the premise that the eye is the portal to the brain.  Research has shown the detection of abnormal eye reflexes can indicate the presence of over 200 diseases and medical conditions.

For more than 25 years, NKI has supplied comprehensive diagnostic tools to audiologists, ENT's, neuro-otologists, neuro-ophthalmologists and neurologists around the globe.  The company's patented products include the I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training and support services. MEDIA CONTACTJohn BuckmanBuckman Communications, for Neuro Kinetics, Inc.+ 1 412-381-2900 or

SOURCE Neuro Kinetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
3. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
4. Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer
5. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
6. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
7. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
8. Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
11. Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015   HeartWare International, Inc ... less-invasive, miniaturized circulatory support technologies that are revolutionizing the ... and Chief Executive Officer Doug Godshall is ... Annual Healthcare Conference on December 1, 2015 at ... 1-2 in New York . ...
(Date:11/24/2015)... 24, 2015  Ascendant Solutions, Inc. (Pink Sheets: ASDS ... of Directors has declared a special 1 percent stock dividend ... payable December 14, 2015, to shareholders of record December 7, ... additional shares of common stock. --> ... a strong endorsement of our confidence in Ascendant,s growth strategy ...
(Date:11/24/2015)... Nov. 24, 2015  Figure 1, a free mobile-first ... medical cases, has launched a new completely redesigned web ... version allows radiologists, who work primarily on a desktop, ... engage with its radiologist user base, Figure 1 is ... North America (RSNA) Annual Meeting. ...
Breaking Medicine Technology:
(Date:11/24/2015)... City, UT (PRWEB) , ... November 24, 2015 , ... ... Forbes Magazine. For a business, it is critical that the first impression be positive ... business, they are not likely to buy anything or want to return. They will ...
(Date:11/24/2015)... ... 2015 , ... In response to recent news highlighting Oxycodone fraud, Novus Medical ... the United States grew 400 percent between 1999 and 2010, far more than the ... percent of all fatal drug overdoses. (1) , While oxycodone and the extended release ...
(Date:11/24/2015)... ... November 24, 2015 , ... The American Association ... their local poison centers through donations on Tuesday, Dec. 1, 2015. Since 2012, ... day that inspires people to collaborate in improving their local communities and help ...
(Date:11/24/2015)... ... 24, 2015 , ... With Thanksgiving right around the corner, holiday travel season ... protect your family and vehicle. , According to the National Highway Traffic Safety Administration, ... is sharing the following safety tips from the NHTSA: , ...
(Date:11/24/2015)... ... November 24, 2015 , ... Abington Hospital ... Aetna Institute of Quality® Bariatric Surgery Facility for treating individuals living with morbid ... health care services available to its members to help them make informed decisions ...
Breaking Medicine News(10 mins):